Ishita Drugs and Industries Limited (ISHITADR.BO)
INR 78.0
(0.22%)
INR 78.0
(0.22%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 108.08 Million INR | -5.25% |
| 2022 | 114.07 Million INR | 1.36% |
| 2021 | 112.53 Million INR | 21.47% |
| 2020 | 92.64 Million INR | -2.94% |
| 2019 | 95.45 Million INR | 14.5% |
| 2018 | 83.36 Million INR | 16.52% |
| 2017 | 71.54 Million INR | -0.45% |
| 2016 | 71.87 Million INR | -12.25% |
| 2015 | 81.9 Million INR | 17.82% |
| 2014 | 69.51 Million INR | 5.18% |
| 2013 | 66.09 Million INR | -17.21% |
| 2012 | 79.83 Million INR | 0.0% |
| 2009 | 60.95 Million INR | 27.26% |
| 2008 | 47.89 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 108.08 Million INR | -5.25% |
| 2023 Q2 | 129.71 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 108.08 Million INR | 0.0% |
| 2022 Q4 | 114.07 Million INR | 0.0% |
| 2022 Q2 | 103.54 Million INR | 0.0% |
| 2022 FY | 114.07 Million INR | 1.36% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 112.53 Million INR | 21.47% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 103.23 Million INR | 0.0% |
| 2021 Q4 | 112.53 Million INR | 0.0% |
| 2020 Q2 | 85.69 Million INR | 0.0% |
| 2020 FY | 92.64 Million INR | -2.94% |
| 2020 Q4 | 92.64 Million INR | 0.0% |
| 2019 Q2 | 99.1 Million INR | 0.0% |
| 2019 FY | 95.45 Million INR | 14.5% |
| 2019 Q4 | 95.45 Million INR | 0.0% |
| 2018 Q4 | 83.36 Million INR | 0.0% |
| 2018 FY | 83.36 Million INR | 16.52% |
| 2018 Q2 | 75.89 Million INR | 0.0% |
| 2017 Q2 | 73.52 Million INR | 0.0% |
| 2017 FY | 71.54 Million INR | -0.45% |
| 2017 Q4 | 71.54 Million INR | 0.0% |
| 2016 Q4 | 71.87 Million INR | 0.0% |
| 2016 Q2 | 74.88 Million INR | 0.0% |
| 2016 FY | 71.87 Million INR | -12.25% |
| 2015 Q4 | 81.9 Million INR | 0.0% |
| 2015 FY | 81.9 Million INR | 17.82% |
| 2014 FY | 69.51 Million INR | 5.18% |
| 2014 Q4 | 69.51 Million INR | 0.0% |
| 2013 Q4 | 66.09 Million INR | 0.0% |
| 2013 FY | 66.09 Million INR | -17.21% |
| 2012 Q4 | 79.83 Million INR | 0.0% |
| 2012 FY | 79.83 Million INR | 0.0% |
| 2009 FY | 60.95 Million INR | 27.26% |
| 2009 Q4 | 60.95 Million INR | 0.0% |
| 2008 FY | 47.89 Million INR | 0.0% |
| 2008 Q4 | 47.89 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Beryl Drugs Limited | 174.86 Million INR | 38.19% |
| ANG Lifesciences India Limited | 2.42 Billion INR | 95.542% |
| Add-Shop E-Retail Limited | 1.25 Billion INR | 91.419% |
| Bacil Pharma Limited | 13.26 Million INR | -715.074% |
| BDH Industries Limited | 934.11 Million INR | 88.429% |
| Cian Healthcare Limited | 1.61 Billion INR | 93.294% |
| Chemo Pharma Laboratories Limited | 130.15 Million INR | 16.953% |
| Colinz Laboratories Limited | 113.59 Million INR | 4.848% |
| Mercury Laboratories Limited | 679.57 Million INR | 84.095% |
| Concord Drugs Limited | 588.06 Million INR | 81.62% |
| Deccan Health Care Limited | 1.08 Billion INR | 89.996% |
| DECIPHER LABS LIMITED | 336.33 Million INR | 67.863% |
| Phaarmasia Limited | 314.47 Million INR | 65.63% |
| Gujarat Terce Laboratories Limited | 232.73 Million INR | 53.558% |
| Gujarat Themis Biosyn Limited | 2.21 Billion INR | 95.112% |
| Hindustan Bio Sciences Limited | 33.74 Million INR | -220.324% |
| Jenburkt Pharmaceuticals Limited | 1.65 Billion INR | 93.453% |
| KIMIA BIOSCIENCES LIMITED | 999.66 Million INR | 89.188% |
| Kwality Pharmaceuticals Limited | 3.94 Billion INR | 97.258% |
| Makers Laboratories Limited | 1.61 Billion INR | 93.297% |
| Medi-Caps Limited | 1.27 Billion INR | 91.508% |
| MedPlus Health Services Limited | 30.04 Billion INR | 99.64% |
| Parmax Pharma Limited | 176.12 Million INR | 38.631% |
| Parnax Lab Limited | 1.88 Billion INR | 94.274% |
| Patidar Buildcon Limited | 94.27 Million INR | -14.65% |
| PRAVEG LIMITED | 3.64 Billion INR | 97.035% |
| Sastasundar Ventures Limited | 11.49 Billion INR | 99.06% |
| Smruthi Organics Limited | 1.18 Billion INR | 90.855% |
| SUDARSHAN PHARMA INDUSTRIES LI | 2.83 Billion INR | 96.182% |
| Sunil Healthcare Limited | 1.58 Billion INR | 93.181% |
| Syschem (India) Limited | 1.64 Billion INR | 93.41% |
| Sanjivani Paranteral Limited. | 434.05 Million INR | 75.098% |
| Transchem Limited | 763.18 Million INR | 85.837% |
| SHAMROCK INDUSTRIAL CO.LTD. | 17.6 Million INR | -514.096% |
| Trinity League India Limited | 32.38 Million INR | -233.746% |
| Tyche Industries Limited | 1.36 Billion INR | 92.105% |
| Source Natural Foods and Herbal Supplements Limited | 236.5 Million INR | 54.299% |
| Trident Lifeline Limited | 870.76 Million INR | 87.587% |
| Denis Chem Lab Limited | 1.09 Billion INR | 90.115% |
| Vista Pharmaceuticals Limited | 579.79 Million INR | 81.358% |
| Panchsheel Organics Limited | 1.59 Billion INR | 93.204% |
| Zenith Healthcare Limited | 97.41 Million INR | -10.957% |
| Zenlabs Ethica Limited | 402.58 Million INR | 73.152% |
| Vivanza Biosciences Limited | 195.01 Million INR | 44.575% |
| Vikram Thermo (India) Limited | 1.42 Billion INR | 92.424% |
| SHELTER PHARMA LIMITED | 379.14 Million INR | 71.492% |
| Vasundhara Rasayans Limited | 373.03 Million INR | 71.025% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1.88 Billion INR | 94.27% |
| Roopa Industries Limited | 647.82 Million INR | 83.315% |
| PANJON LTD. | 173.91 Million INR | 37.85% |
| Pharmaids Pharmaceuticals Limited | 913.4 Million INR | 88.167% |
| TIAAN CONSUMER LIMITED | 95.12 Million INR | -13.627% |
| Anuh Pharma Limited | 4.45 Billion INR | 97.575% |
| Crestchem Limited | 71.44 Million INR | -51.293% |
| Emmessar Biotech & Nutrition Limited | 87.42 Million INR | -23.628% |
| Sandu Pharmaceuticals Limited | 524.14 Million INR | 79.379% |
| Fredun Pharmaceuticals Limited | 3.07 Billion INR | 96.486% |
| Trimurthi Limited | 73.64 Million INR | -46.76% |
| Shukra Pharmaceuticals Limited | 778.37 Million INR | 86.114% |
| Norris Medicines Limited | 141.87 Million INR | 23.814% |
| Veerhealth Care Limited | 281.16 Million INR | 61.558% |
| Lactose (India) Limited | 1 Billion INR | 89.271% |
| OXYGENTA PHARMACEUTICAL LIMITE | 631.92 Million INR | 82.895% |
| Ambalal Sarabhai Enterprises Limited | 2.5 Billion INR | 95.68% |
| Gennex Laboratories Limited | 2.29 Billion INR | 95.3% |
| Godavari Drugs Limited | 1.34 Billion INR | 91.979% |
| Zenotech Laboratories Limited | 1.06 Billion INR | 89.823% |
| Shree Ganesh Remedies Limited | 1.7 Billion INR | 93.677% |
| Bharat Parenterals Limited | 5.03 Billion INR | 97.855% |
| Coral Laboratories Limited | 2.05 Billion INR | 94.745% |
| Evoq Remedies Limited | 368.61 Million INR | 70.677% |
| Kerala Ayurveda Limited | 1.4 Billion INR | 92.329% |
| KOBO BIOTECH LIMITED | 713.93 Million INR | 84.86% |
| Natural Capsules Limited | 3.76 Billion INR | 97.129% |
| Auro Laboratories Limited | 852.67 Million INR | 87.324% |